Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Antibiotice has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Antibiotice's Piotroski F-Score or its related term are showing as below:
BSE:ATB'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 9
Current: 6
During the past 13 years, the highest Piotroski F-Score of Antibiotice was 9. The lowest was 3. And the median was 6.
Antibiotice Piotroski F-Score Historical Data
The historical data trend for Antibiotice's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Antibiotice's Piotroski F-Score
For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Antibiotice's Piotroski F-Score Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Antibiotice's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Antibiotice's Piotroski F-Score falls into.
How is the Piotroski F-Score calculated?
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Dec23) TTM:
Last Year (Dec22) TTM:
Net Income was 22.203 + 39.799 + 14.731 + 4.355 = lei81.1 Mil. Cash Flow from Operations was -2.647 + 36.011 + 28.165 + 60.931 = lei122.5 Mil. Revenue was 178.726 + 137.145 + 147.56 + 137.349 = lei600.8 Mil. Gross Profit was 105.379 + 124.412 + 84.714 + 94.898 = lei409.4 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(984.321 + 914.037 + 953.345 + 969.018 + 1139.172) / 5 = lei991.9786 Mil. Total Assets at the begining of this year (Dec22) was lei984.3 Mil. Long-Term Debt & Capital Lease Obligation was lei36.8 Mil. Total Current Assets was lei401.3 Mil. Total Current Liabilities was lei190.5 Mil.
Net Income was 8.631 + 25.345 + -4.489 + 21.985 = lei51.5 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Antibiotice's current Net Income (TTM) was 81.1.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Antibiotice's return on assets of this year was 0.08237963. Antibiotice's return on assets of last year was 0.05748556.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Antibiotice's gearing of this year was 0.03704717. Antibiotice's gearing of last year was 0.05193608.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Antibiotice's current ratio of this year was 2.10680947. Antibiotice's current ratio of last year was 2.5727308.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Antibiotice's number of shares in issue this year was 671.349. Antibiotice's number of shares in issue last year was 671.338.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Antibiotice's gross margin of this year was 0.68145245. Antibiotice's gross margin of last year was 0.68649685.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Antibiotice's asset turnover of this year was 0.61034967. Antibiotice's asset turnover of last year was 0.54023833.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
0
+
0
+
0
+
1
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Antibiotice has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Antibiotice Piotroski F-Score Related Terms
Thank you for viewing the detailed overview of Antibiotice's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSE:ATB has been successfully added to your 